Comparison of Treatment Safety and Patient Survival in Elderly versus Nonelderly Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib Combined with Transarterial Chemoembolization: A Propensity Score Matching Study

• Hao Hu,

  Affiliation Department of Interventional Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

  ⨯
• Zhenhua Duan,

  Affiliation Chengdu Center for Disease Control and Prevention, Chengdu, China

  ⨯
• Xiaoran Long,

  Affiliation School of Pharmacy, Anhui Medical University, Hefei, China

  ⨯
• Yancu Hertzanu,

  Affiliation Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel

  ⨯
• Xiaoqiang Tong,

  Affiliation Department of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing, China

  ⨯
• Xiaoquan Xu,

  Affiliation Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

  ⨯
• Haibin Shi,

  Affiliation Department of Interventional Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

  ⨯
• Sheng Liu,

  Affiliation Department of Interventional Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

  ⨯
• Zhengqiang Yang

  * E-mail: olivialong@sina.cn

  Affiliation Department of Interventional Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

  ⨯